Clinical Trial Update: Safety and Preliminary Efficacy of IVMED-80 Eye Drops in Keratoconus Patients [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update reporting safety and preliminary efficacy data for IVMED-80 Eye Drops in keratoconus patients (Phase 1/Phase 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Ectasia
• Keratoconus

Drugs mentioned

• IVMED-80 Eye Drops (IVMED-80 Eye Drops)

Snippet

Sponsor: iVeena Delivery Systems, Inc. | Conditions: Keratoconus, Corneal Ectasia | Phase 1, Phase 2 | Status: COMPLETED